ecteinascidin 743 has been researched along with epothilone a in 5 studies
Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (epothilone a) | Trials (epothilone a) | Recent Studies (post-2010) (epothilone a) |
---|---|---|---|---|---|
660 | 102 | 404 | 904 | 144 | 360 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
von Mehren, M | 1 |
Dean-Colomb, W; Esteva, FJ | 1 |
Bailly, C | 1 |
Monneret, C | 1 |
Trendowski, M | 1 |
4 review(s) available for ecteinascidin 743 and epothilone a
Article | Year |
---|---|
New therapeutic strategies for soft tissue sarcomas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials as Topic; Dioxoles; Docetaxel; Epothilones; Guanidines; Humans; Indoles; Isoquinolines; Protein Kinase Inhibitors; Protein Kinases; Pyrazines; Pyrroles; Sarcoma; Sirolimus; Sunitinib; Taxoids; Tetrahydroisoquinolines; TOR Serine-Threonine Kinases; Trabectedin | 2003 |
Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Clinical Trials as Topic; Deoxycytidine; Dioxoles; Diphtheria Toxin; Drug Resistance, Neoplasm; Drugs, Investigational; Epothilones; Female; Furans; Gemcitabine; Glutamates; Guanine; Humans; Interleukin-2; Ketones; Lapatinib; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pemetrexed; Quinazolines; Recombinant Fusion Proteins; Tetrahydroisoquinolines; Trabectedin; Vinblastine; Vinorelbine | 2008 |
[Current impact of natural products in the discovery of anticancer drugs].
Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bioengineering; Biological Products; Clinical Trials as Topic; Combinatorial Chemistry Techniques; Dioxoles; Drug Approval; Drug Discovery; Drug Screening Assays, Antitumor; Drugs, Investigational; Epothilones; Everolimus; Gemtuzumab; Humans; Immunoconjugates; Maytansine; Sirolimus; Tetrahydroisoquinolines; Trabectedin; United States; United States Food and Drug Administration; Vinblastine | 2010 |
Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products.
Topics: Antineoplastic Agents; Biological Products; Cytochalasins; Dioxoles; Diphtheria Toxin; Drug Discovery; Epothilones; Furans; Harringtonines; Homoharringtonine; Humans; Immunoconjugates; Interleukin-2; Ketones; Recombinant Fusion Proteins; Tetrahydroisoquinolines; TOR Serine-Threonine Kinases; Trabectedin; Withanolides | 2015 |
1 other study(ies) available for ecteinascidin 743 and epothilone a
Article | Year |
---|---|
Ready for a comeback of natural products in oncology.
Topics: Antineoplastic Agents; Biological Products; Dioxoles; Epothilones; Humans; Neoplasms; Sirolimus; Tetrahydroisoquinolines; Trabectedin | 2009 |